Literature DB >> 21390570

Crosstalk of TGF-β and estrogen receptor signaling in breast cancer.

Arja M Band1, Marikki Laiho.   

Abstract

Estrogen receptor-α (ERα) and transforming growth factor (TGF)-β signaling pathways are major regulators during mammary gland development, function and tumorigenesis. Predominantly, they have opposing roles in proliferation and apoptosis. While ERα signaling supports growth and differentiation and is antiapoptotic, mammary gland epithelia cells are very sensitive to TGF-β-induced cell cycle arrest and apoptosis. Their regulatory pathways intersect, and ERα blocks TGF-β pathway by multiple means, including direct interactions of its signaling components, Smads. However, relatively little is known of the dysfunction of their interactions in cancer. A better understanding would help to develop new strategies for breast cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21390570     DOI: 10.1007/s10911-011-9203-7

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  80 in total

1.  Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation.

Authors:  T Ebisawa; M Fukuchi; G Murakami; T Chiba; K Tanaka; T Imamura; K Miyazono
Journal:  J Biol Chem       Date:  2001-02-13       Impact factor: 5.157

2.  Estrogen receptors inhibit Smad3 transcriptional activity through Ap-1 transcription factors.

Authors:  Tracy Cherlet; Leigh C Murphy
Journal:  Mol Cell Biochem       Date:  2007-07-28       Impact factor: 3.396

3.  A signature motif in transcriptional co-activators mediates binding to nuclear receptors.

Authors:  D M Heery; E Kalkhoven; S Hoare; M G Parker
Journal:  Nature       Date:  1997-06-12       Impact factor: 49.962

4.  Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells.

Authors:  Jeffery S Edmiston; W Andrew Yeudall; Theodore D Chung; Deborah A Lebman
Journal:  Cancer Res       Date:  2005-06-01       Impact factor: 12.701

5.  TGF-beta induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation.

Authors:  S Bonni; H R Wang; C G Causing; P Kavsak; S L Stroschein; K Luo; J L Wrana
Journal:  Nat Cell Biol       Date:  2001-06       Impact factor: 28.824

6.  The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling.

Authors:  K Luo; S L Stroschein; W Wang; D Chen; E Martens; S Zhou; Q Zhou
Journal:  Genes Dev       Date:  1999-09-01       Impact factor: 11.361

7.  The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha.

Authors:  Archana Dhasarathy; Masahiro Kajita; Paul A Wade
Journal:  Mol Endocrinol       Date:  2007-08-30

8.  Transforming growth factor-beta suppresses the ability of Ski to inhibit tumor metastasis by inducing its degradation.

Authors:  Erwan Le Scolan; Qingwei Zhu; Long Wang; Abhik Bandyopadhyay; Delphine Javelaud; Alain Mauviel; LuZhe Sun; Kunxin Luo
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

9.  Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle.

Authors:  E A Musgrove; C S Lee; M F Buckley; R L Sutherland
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

10.  Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase.

Authors:  S Kato; H Endoh; Y Masuhiro; T Kitamoto; S Uchiyama; H Sasaki; S Masushige; Y Gotoh; E Nishida; H Kawashima; D Metzger; P Chambon
Journal:  Science       Date:  1995-12-01       Impact factor: 47.728

View more
  38 in total

1.  Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.

Authors:  Yong-Hun Lee; William P Schiemann
Journal:  Breast Cancer Manag       Date:  2014

Review 2.  The role of cytokines in breast cancer development and progression.

Authors:  Marcela Esquivel-Velázquez; Pedro Ostoa-Saloma; Margarita Isabel Palacios-Arreola; Karen E Nava-Castro; Julieta Ivonne Castro; Jorge Morales-Montor
Journal:  J Interferon Cytokine Res       Date:  2014-07-28       Impact factor: 2.607

3.  TGF-β Stimulation of EMT Programs Elicits Non-genomic ER-α Activity and Anti-estrogen Resistance in Breast Cancer Cells.

Authors:  Maozhen Tian; William P Schiemann
Journal:  J Cancer Metastasis Treat       Date:  2017-08-21

4.  Girl power: estrogen promotes HSC self-renewal.

Authors:  Esther Carreras; Susan Kovats
Journal:  Cell Stem Cell       Date:  2014-02-06       Impact factor: 24.633

5.  Placenta-breast cancer cell interactions promote cancer cell epithelial mesenchymal transition via TGFβ/JNK pathway.

Authors:  Gali Epstein Shochet; Shelly Tartakover-Matalon; Liat Drucker; Metsada Pasmanik-Chor; Meir Pomeranz; Ami Fishman; Michael Lishner
Journal:  Clin Exp Metastasis       Date:  2014-10-15       Impact factor: 5.150

6.  Estrogen-related receptor α participates transforming growth factor-β (TGF-β) induced epithelial-mesenchymal transition of osteosarcoma cells.

Authors:  Yantao Chen; Kunshui Zhang; Yang Li; Qing He
Journal:  Cell Adh Migr       Date:  2016-08-17       Impact factor: 3.405

7.  SnoN oncoprotein enhances estrogen receptor-α transcriptional activity.

Authors:  Arja M Band; Marikki Laiho
Journal:  Cell Signal       Date:  2011-12-29       Impact factor: 4.315

8.  Transforming growth factor-β signaling pathway cross-talking with ERα signaling pathway on regulating the growth of uterine leiomyoma activated by phenolic environmental estrogens in vitro.

Authors:  Yang Shen; Yanting Wu; Qing Lu; Peili Zhang; Mulan Ren
Journal:  Tumour Biol       Date:  2015-07-30

9.  Transforming growth factor beta1 (TGFβ1) polymorphisms and breast cancer risk.

Authors:  Davar Amani; Ahad Khalilnezhad; Abbas Ghaderi; Norrio Niikawa; Ko-ichiro Yoshiura
Journal:  Tumour Biol       Date:  2014-01-15

10.  Associations between genetic variants in the TGF-β signaling pathway and breast cancer risk among Hispanic and non-Hispanic white women.

Authors:  Stephanie D Boone; Kathy B Baumgartner; Richard N Baumgartner; Avonne E Connor; Christina M Pinkston; Esther M John; Lisa M Hines; Mariana C Stern; Anna R Giuliano; Gabriela Torres-Mejia; Guy N Brock; Frank D Groves; Richard A Kerber; Roger K Wolff; Martha L Slattery
Journal:  Breast Cancer Res Treat       Date:  2013-09-14       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.